ASHI's Response to Immigration Executive Order
Tuesday, February 7, 2017
As I am sure you are aware, on January 27th, an executive order limiting immigration and visa distribution for several countries was issued by the President of the United States, Donald Trump. No matter your political perspective, this order has the potential to disrupt the worldwide collaboration so necessary for patient care, scientific inquiry and education. I want to make sure that all members of ASHI, domestic and international, understand that we are concerned about potential disruptions and will work with all of our members and accredited laboratories to make sure that the important business of our society continues as smoothly as possible. To underscore that concern, the Executive Committee of the ASHI Board of Directors has unanimously approved placing our organization's imprimatur on this letter to the President from the Association of American Medical Colleges.
I cannot stress enough that ASHI encourages and benefits from working together with our international members and our sister societies in Europe and the Asia-Pacific region. To that end, ASHI, the European Federation for Immunogenetics (EFI) and the Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) have all made a joint resolution for closer cooperation on many areas of mutual interests. This joint resolution, in the works since last year, was approved by the boards of directors of all three societies and will be made available to all members once all of the societies' presidents sign the documents. We are committed to international cooperation. The science and practice of histocompatibility and immunogenetics demand such cooperation for the benefit of all patients we serve!
On behalf of the ASHI Board of Directors,
Michael D. Gautreaux, PhD, D(ABHI)